Events & Promotions
|
|
GMAT Club Daily Prep
Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.
Customized
for You
Track
Your Progress
Practice
Pays
Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.
Apr 2512:30 AM EDT
-01:30 AM EDT
At one point, she believed GMAT wasn’t for her. After scoring 595, self-doubt crept in and she questioned her potential. But instead of quitting, she made the right strategic changes. The result? A remarkable comeback to 695. Check out how Saakshi did it.
Apr 2601:30 AM EDT
-02:30 AM EDT
Learn how Keshav, a Chartered Accountant, scored an impressive 705 on GMAT in just 30 days with GMATWhiz's expert guidance. In this video, he shares preparation tips and strategies that worked for him, including the mock, time management, and more.
Apr 2610:00 AM EDT
-11:00 AM EDT
The Target Test Prep course represents a quantum leap forward in GMAT preparation, a radical reinterpretation of the way that students should study. Try before you buy with a 5-day, full-access trial of the course for FREE!
Apr 2711:00 AM EDT
-12:00 PM EDT
Prefer video-based learning? The Target Test Prep OnDemand course is a one-of-a-kind video masterclass featuring 400 hours of lecture-style teaching by Scott Woodbury-Stewart, founder of Target Test Prep and one of the most accomplished GMAT instructors
Apr 2808:00 AM PDT
-11:00 AM PDT
Whether you are just beginning your MBA journey or fine-tuning your path to a 700+ score, GMAT Day is designed to give you a competitive edge.
May 0111:00 AM PDT
-12:00 PM PDT
Free- full-length test + 15 concept videos + 150+ short videos + study plan!
playthegame
Johnson Moderator
Joined: 19 Jan 2024
Last visit: 28 Mar 2025
Posts: 421
Given Kudos: 146
Location: Canada
Concentration: Operations, Leadership
Schools: Johnson '27
Products:
13 Jul 2024, 15:15
Kudos
Bookmarks
B
Be sure to select an answer first to save it in the Error Log before revealing the correct answer (OA)!
Difficulty:
5%
(low)
Question Stats:
92% (01:13) correct
8%
(01:34)
wrong
based on 460
sessions
History
Date
Time
Result
Not Attempted Yet
For years the arthritis relief medication Exenol has been available without a prescription. This year Parconin was introduced on the market, but, due to government regulations, the drug is available only by prescription. The makers of Parconin argue that it is unfair to restrict access to Parconin while allowing their competition’s product to be sold without restrictions, since the two drugs have the same active ingredient and Parconin’s other ingredients are harmless.
The answer to which of the following would be most useful in evaluating the argument of the Parconin executives?
A. Do the makers of Exenol endorse the recent government regulations?
B. Do the two drugs contain the same quantity of the active ingredient per recommended dose?
C. Do any other drugs have the same active ingredient as Parconin and Exenol?
D. Does Parconin cost significantly more than Exenol?
E. How many prescriptions are written for Parconin each month?
The answer to which of the following would be most useful in evaluating the argument of the Parconin executives?
A. Do the makers of Exenol endorse the recent government regulations?
B. Do the two drugs contain the same quantity of the active ingredient per recommended dose?
C. Do any other drugs have the same active ingredient as Parconin and Exenol?
D. Does Parconin cost significantly more than Exenol?
E. How many prescriptions are written for Parconin each month?
Question exposed a gap?
Take sectional Adaptive Quant, Verbal, or DI tests on GMAT Club and review the detailed score report.
Get started →
14 Jul 2024, 06:35
Kudos
Bookmarks
Pretty straightforward. B should be the answer.
If the parconin contains greater amount than exenol in terms of the active ingredients used per dosage then restricting access only to parconin by doctor s prescription is NOT unfair.
Else if they contain same amount of active ingredients then it's unfair to impose restrictions only on Parconin.
Posted from my mobile device
If the parconin contains greater amount than exenol in terms of the active ingredients used per dosage then restricting access only to parconin by doctor s prescription is NOT unfair.
Else if they contain same amount of active ingredients then it's unfair to impose restrictions only on Parconin.
Posted from my mobile device
14 Jul 2024, 08:53
Kudos
Bookmarks
For years the arthritis relief medication Exenol has been available without a prescription. This year Parconin was introduced on the market, but, due to government regulations, the drug is available only by prescription. The makers of Parconin argue that it is unfair to restrict access to Parconin while allowing their competition’s product to be sold without restrictions, since the two drugs have the same active ingredient and Parconin’s other ingredients are harmless.
The answer to which of the following would be most useful in evaluating the argument of the Parconin executives?
A. Do the makers of Exenol endorse the recent government regulations? - WRONG. Endorsement is irrelevant.
B. Do the two drugs contain the same quantity of the active ingredient per recommended dose? - CORRECT. If dosage differ then one might be having only generic level of ingredient while may have higher level that may not be considered safe for generic selling.
C. Do any other drugs have the same active ingredient as Parconin and Exenol? - WRONG. Out of scope.
D. Does Parconin cost significantly more than Exenol? - WRONG. Cost is irrelevant.
E. How many prescriptions are written for Parconin each month? - WRONG. Like C and D this too is irrelevant.
Simple question is why one drug is openly available while other's not. What might be the difference between the two that make their availablity not comparable?
Answer B.
The answer to which of the following would be most useful in evaluating the argument of the Parconin executives?
A. Do the makers of Exenol endorse the recent government regulations? - WRONG. Endorsement is irrelevant.
B. Do the two drugs contain the same quantity of the active ingredient per recommended dose? - CORRECT. If dosage differ then one might be having only generic level of ingredient while may have higher level that may not be considered safe for generic selling.
C. Do any other drugs have the same active ingredient as Parconin and Exenol? - WRONG. Out of scope.
D. Does Parconin cost significantly more than Exenol? - WRONG. Cost is irrelevant.
E. How many prescriptions are written for Parconin each month? - WRONG. Like C and D this too is irrelevant.
Simple question is why one drug is openly available while other's not. What might be the difference between the two that make their availablity not comparable?
Answer B.
